CL2012000406A1 - Gránulo de liberación controlada que comprende una partícula central que contiene al isómero r-lansoprazol y una capa de recubrimiento de liberación controlada soluble dependiente del ph seleccionada de copolímeros s y l del ácido metacrílico (div. sol. nº 2051-2003). - Google Patents

Gránulo de liberación controlada que comprende una partícula central que contiene al isómero r-lansoprazol y una capa de recubrimiento de liberación controlada soluble dependiente del ph seleccionada de copolímeros s y l del ácido metacrílico (div. sol. nº 2051-2003).

Info

Publication number: CL2012000406A1
Authority: CL; Chile
Prior art keywords: controlled release; lansoprazole; div; isomer; sol
Prior art date: 2002-10-16

Application number

CL2012000406A

Other languages

English (en)

Inventor

Yohko Kurasawa Takashi Bando Hiroto Nagahara Nao Ki Akiyama

Original Assignee

Takeda Pharmaceuticals Co

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2002-10-16

Filing date

2012-02-16

Publication date

2012-09-28

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=33424719&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CL2012000406(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2012-02-16 Application filed by Takeda Pharmaceuticals Co filed Critical Takeda Pharmaceuticals Co

2012-09-28 Publication of CL2012000406A1 publication Critical patent/CL2012000406A1/es

Links

238000013270 controlled release Methods 0.000 title 2
239000011247 coating layer Substances 0.000 title 1
239000007771 core particle Substances 0.000 title 1
230000001419 dependent effect Effects 0.000 title 1
MJIHNNLFOKEZEW-RUZDIDTESA-N dexlansoprazole Chemical class CC1=C(OCC(F)(F)F)C=CN=C1C[S@@](=O)C1=NC2=CC=CC=C2N1 MJIHNNLFOKEZEW-RUZDIDTESA-N 0.000 title 1
239000008187 granular material Substances 0.000 title 1
229920003145 methacrylic acid copolymer Polymers 0.000 title 1

CL2012000406A 2002-10-16 2012-02-16 Gránulo de liberación controlada que comprende una partícula central que contiene al isómero r-lansoprazol y una capa de recubrimiento de liberación controlada soluble dependiente del ph seleccionada de copolímeros s y l del ácido metacrílico (div. sol. nº 2051-2003). CL2012000406A1 (es)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
JP2002301876		2002-10-16
JP2003066336		2003-03-12
JP2003354900A JP4493970B2 (ja)	2002-10-16	2003-10-15	持続性製剤

Publications (1)

Publication Number	Publication Date
CL2012000406A1 true CL2012000406A1 (es)	2012-09-28

Family

ID=33424719

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
CL2012000406A CL2012000406A1 (es)	2002-10-16	2012-02-16	Gránulo de liberación controlada que comprende una partícula central que contiene al isómero r-lansoprazol y una capa de recubrimiento de liberación controlada soluble dependiente del ph seleccionada de copolímeros s y l del ácido metacrílico (div. sol. nº 2051-2003).

Country Status (2)

Country	Link
JP (1)	JP4493970B2 (es)
CL (1)	CL2012000406A1 (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
RU2496480C2 (ru)	2005-12-28	2013-10-27	Такеда Фармасьютикал Компани Лимитед	Твердый препарат с контролируемым высвобождением
CA2927045A1 (en) *	2006-10-03	2008-04-10	Muthiah Manoharan	Lipid containing formulations
WO2009049160A1 (en) *	2007-10-12	2009-04-16	Takeda Pharmaceuticals North America	Methods of treating gastrointestinal disorders independent of the intake of food
TWI441658B (zh)	2008-03-11	2014-06-21	Takeda Pharmaceutical	口腔崩解固體製劑
MX2013007588A (es)	2010-12-27	2013-08-09	Takeda Pharmaceutical	Comprimido de desintegracion oral.
WO2013058409A1 (en)	2011-10-21	2013-04-25	Takeda Pharmaceutical Company Limited	Sustained-release preparation

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JPH07121859B2 (ja) *	1986-03-18	1995-12-25	第一製薬株式会社	徐放性カプセル剤
EP0951278A2 (en) *	1997-01-03	1999-10-27	ELAN CORPORATION, Plc	Sustained release cisapride mini-tablet formulation
SE9704869D0 (sv) *	1997-12-22	1997-12-22	Astra Ab	New pharmaceutical formulaton II
TW585786B (en) *	1998-07-28	2004-05-01	Takeda Chemical Industries Ltd	Lansoprazole-containing rapidly disintegrable solid pharmaceutical composition
JP2000119181A (ja) *	1998-10-06	2000-04-25	Kureha Chem Ind Co Ltd	エスクレチン及びその誘導体の放出制御経口製剤
JP5412023B2 (ja) *	2000-08-04	2014-02-12	武田薬品工業株式会社	ベンズイミダゾール化合物の塩およびその用途

2003
- 2003-10-15 JP JP2003354900A patent/JP4493970B2/ja not_active Expired - Lifetime
2012
- 2012-02-16 CL CL2012000406A patent/CL2012000406A1/es unknown

Also Published As

Publication number	Publication date
JP2004292427A (ja)	2004-10-21
JP4493970B2 (ja)	2010-06-30

Similar Documents

Publication	Publication Date	Title
CL2012000406A1 (es)	2012-09-28	Gránulo de liberación controlada que comprende una partícula central que contiene al isómero r-lansoprazol y una capa de recubrimiento de liberación controlada soluble dependiente del ph seleccionada de copolímeros s y l del ácido metacrílico (div. sol. nº 2051-2003).
ATE391496T1 (de)	2008-04-15	Geschmacksmaskierte pharmazeutische formulierungen
DE60020122D1 (de)	2005-06-16	Photochrome Beschichtungszusammensetzung enthaltend Poly(meth)acrylate
NO20013106D0 (no)	2001-06-21	Polyelektrolyttbelagt, permeabel kompositt, fremgangsmåte til dens fremstilling og anvendelse av kompositten
ATE268593T1 (de)	2004-06-15	Bupropionhydrochlorid enthaltende tabletten mit gesteuerter wirkstoffabgabe
JP2003512395A5 (es)	2007-11-22
DE60112656D1 (de)	2005-09-22	Beschichtungszusammensetzung, Beschichtungsverfahren und beschichteter Gegenstand
WO2004071341A3 (en)	2005-04-14	Disposable absorbent article comprising a durable hydrophilic core wrap
ATE512659T1 (de)	2011-07-15	Tablette mit verzögerter wirkstofffreigabe und bestimmter formgeometrie
PT1390438E (pt)	2005-04-29	Concentrado anticongelante que contem o corante c.i. reactivo violeta
WO2003084518A3 (fr)	2004-04-01	Suspension orale de microcapsules de principes actifs
MXPA03003545A (es)	2003-10-14	Metodo para elaborar articulos revestidos, y los articulos revestidos a partir del mismo.
DE60209235D1 (de)	2006-04-20	Geprägte unterlagsscheibe
WO2002011702A3 (en)	2002-11-28	Hydrogel-driven drug dosage form
DE60323474D1 (de)	2008-10-23	Orale pharmazeutische formulierung in form einer wässrigen suspension von mikrokapseln zur modifizierten freisetzung von amoxicillin
DE60105665D1 (de)	2004-10-28	Beschichtungszusammensetzung, Beschichtungsverfahren und beschichtete Gegenstände
NO20023263D0 (no)	2002-07-05	Fremgangsmåte, system, returautomat og anvendelse ved håndtering av tomemballasje
NO20022362D0 (no)	2002-05-16	Belegging av tablettkjerner
AU2002336579A1 (en)	2003-04-01	Porously coated open-structure substrate and method of manufacture thereof
WO2009090484A3 (en)	2010-03-25	Mesalazine tablet
DE60120262T8 (de)	2007-07-19	Aus unterschiedlichen Metallen zusammengesetzte Bremsscheibe und Verfahren zu deren Herstellung
WO2002072072A3 (fr)	2002-12-27	Granules et granules enrobes au gout masque
IT1318524B1 (it)	2003-08-27	Composizioni a rilascio controllato contenenti un principio attivo,preferibilmente melatonina, e processo di preparazione delle stesse.
AU2002363560A1 (en)	2003-05-19	Optical disk, card or media and method for coating of said optical disk, card or media
SG114577A1 (en)	2005-09-28	Spool case for bonding wire, and method of handling spool using same